Rajesh Malik G1 Therapeutics, Inc. (GTHX) insider trading activity
Rajesh Malik is Chief Medical Officer of G1 Therapeutics, Inc.. Currently has a direct ownership of 161,787 shares of GTHX, which is worth approximately $406,085. The most recent transaction as insider was on Mar 02, 2021, when has been sold 15,000 shares (Common Stock) at a price of $22.95 per share, resulting in proceeds of $344,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
162K
4.8%
3M change
18.63%
12M change
Total Value Held
$406,085
Rajesh Malik Transaction History
Also insider at
RM
Rajesh Malik
Chief Medical Officer
Research Triangle Park, NC